Fundraising Fox
🦊/Companies
Sign in

VitriVax

Boulder, US · Delaware corporation · 4 known investors

Find your way into VitriVax

171 people in our graph share verified history with the VitriVax team — schools, employers, funds. One of them is your warm intro.

Sam Blackmanunlockedknows Romulo Colindres · together at GSK (overlapped)
×11knows the team · via GSK
Biotech

Founders & leadership

TRTheodore Randolph
Theodore RandolphFounder
RCRomulo Colindres
Romulo ColindresinExecutiveRomulo Colindres is a pharmaceutical executive with experience in medical affairs, epidemiology, clinical development, market access, regulatory affairs, and pharmacovigilance. He leads VitriVax as executive officer and director.

Board

GRGlenn Rockman
Glenn Rockmanin𝕏Board directorCo-Founder and Partner at Adjuvant Capital
RL
Rene LorenzBoard director
LB
Louise BradyBoard director

Investors · 4

Buff Gold VenturesBoulder
CU Healthcare Innovation FundAurora
RA CapitalBoston
Adjuvant Capitalreported · 3 sourcesNew York · $10M – $25M

Funding

SEC filings, press & company announcements

$29.4M disclosed across 1 of 2 rounds · 2021–2025

▶$29.4MraisedNov 2025 · 83 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Glenn RockmanDirector
  • Rene LorenzDirector
  • Louise BradyDirector
  • Theodore RandolphDirector
  • Romulo ColindresExecutive Officer, Director, Promoter
Offering amount
$37.1M
Amount sold
$29.4M
First sale
Jun 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Trysignalbasetrysignalbase.com · Jan 2026VitriVax Raises $17.25 Million Series B Financing to Advance Vaccine Formulation Platform - BioSpacebiospace.com · Oct 2025VitriVax: $17.25 Million Series B Closed To Advance Thermostable Single-Shot Vaccine Platformpulse2.com · Oct 2025VitriVax Raises $17.25M in Series B Financingfinsmes.com · Oct 2025VitriVax Awarded $9.9M Grant to Enable Scaling up of Clinical Manufacturingbusinesswire.com · Oct 2025VitriVax Announces Series A Financing to Further Demonstrate Feasibility of its Thermostable, Single-Dose Vaccine Technology, Aiming to Make Life-Saving Biologics Widely Accessible to Underserved Populations Globally - Colorado Bioscience Associationcobioscience.com · Jul 2021

Frequently asked questions

Who founded VitriVax?
VitriVax was founded by Theodore Randolph.
Who are VitriVax's investors?
VitriVax's investors include Buff Gold Ventures, CU Healthcare Innovation Fund, RA Capital, Adjuvant Capital.
How much funding has VitriVax raised?
VitriVax has disclosed $29.4M raised across 1 of its 2 known rounds.
Where is VitriVax headquartered?
VitriVax is headquartered in Boulder, US.